Article

KidneyCAN YouTube Channel

KidneyCan hosts a YouTube channel where research news, patient education, and legislative advocacy videos keep our community connected to the latest developments.

KidneyCan hosts a YouTube channel where research news, patient education, and legislative advocacy videos keep our community connected to the latest developments. Check it out and follow us to stay informed!

Related Videos
Dr. Ged in an interview with CURE at the 2023 KCRS
Dr. Toni Choueiri in an interview with CURE at the 2023 KCRS
Dr. Hannan in an interview with CURE at the KCRS conference
Related Content
Image of a patient receiving radiation therapy.
March 29th 2024

What Patients With Kidney Cancer Need to Know About Radiation Therapy

Alex Biese
An expert explains what patients need to keep in mind and what conversations they should be having with their care teams.
kidneys
July 21st 2023

Research Continues for Best Immunotherapy Order in Advanced RCC

Kyle Doherty
Even with the increase of immunotherapy utilization to treat patients with advanced renal cell carcinoma, more research is needed to determine in which order to administer it as later lines of therapy.
image of clear cell renal cell carcinoma
July 19th 2023

How Cancer Teams Leverage Biology in Guiding First-Line Therapy for Clear Cell RCC

Brittany Lovely
An expert explained what aspects of a patient’s disease cancer care teams use to determine the best treatment options for patients with clear cell renal cell carcinoma.
Kidneys reflecting off of an iPad tablet
July 18th 2023

BAP1-Mutated RCC Responds to Treatment with Lynparza

Kristi Rosa
Patients with BAP1-mutated renal cell carcinoma who were treated with Lynparza obtained responses with favorable side effect profiles.
stethoscope, vial, and pills
July 17th 2023

New Drugs Being Explored in Kidney Cancer

Chris Ryan
An expert gives an overview of up-and-coming treatments for patients with kidney cancer.
colorful kidneys
July 16th 2023

Drug Duo Continues to Show Promise in Advanced Kidney Cancer

Gina Mauro
Long-term follow-up data showed that Lenvima plus Keytruda continued to show benefit in patients with metastatic kidney cancer.